Keywords: Sucampo, Abbott, Amitiza, Constipation, Japan, Optimer, Dificid, Canada, Infection, Sigma-Tau, Eurartesim, Malaria

Regulatory briefs: Amitiza in Japan; Dificid in Canada; Eurartesim roll-out

Article | 06 July 2012

Print This

Sucampo Pharmaceuticals (Nasdaq: SCMP) and Abbott Labs (NYSE: ABT) have received approval from the Ministry of Health, Labor and Welfare ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in